Frontotemporal Dementia [clinicaltrials_resource:b64b03a2389f48acfcdff013beb89734]
Amyotrophic Lateral Sclerosis and Frontotemporal Dementia [clinicaltrials:NCT00159198]Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia [clinicaltrials:NCT00376051]A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia [clinicaltrials:NCT00416169]clinicaltrials:NCT00594737Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease. [clinicaltrials:NCT00938665]clinicaltrials:NCT00950430Oxytocin and Social Cognition in Frontotemporal Dementia [clinicaltrials:NCT01002300]Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls [clinicaltrials:NCT01147679]Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD) [clinicaltrials:NCT01353430]Safety Study of Intranasal Oxytocin in Frontotemporal Dementia [clinicaltrials:NCT01386333]Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders [clinicaltrials:NCT01459302]A Composite MR Neuroimaging Marker for Alzheimer's Disease [clinicaltrials:NCT01615666]clinicaltrials:NCT01890343clinicaltrials:NCT01937013clinicaltrials:NCT02050464clinicaltrials:NCT02055092Study of the Neural Basis of Analogical Reasoning [clinicaltrials:NCT02236832]Phenotype, Genotype & Biomarkers in ALS and Related Disorders [clinicaltrials:NCT02327845]Clinical Utility of Flutemetamol in the Differential Diagnosis and Prognosis of Alzheimer's and Frontotemporal Dementia [clinicaltrials:NCT02353949]Communication Bridge Speech Therapy Research Study [clinicaltrials:NCT02439853]Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated. [clinicaltrials:NCT02496312]Efficacy of Web-Based Social-Cognitive Interventions in Right Hemisphere Stroke and Frontotemporal Dementia [clinicaltrials:NCT02506036]
condition [clinicaltrials_vocabulary:condition]
PET Scan of Brain Metabolism in Relation to Age and Disease [clinicaltrials:NCT00001972]Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00005900]Direct Current Brain Polarization in Frontotemporal Dementia [clinicaltrials:NCT00077896]Treatment Study of Frontotemporal Dementia [clinicaltrials:NCT00088751]Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD) [clinicaltrials:NCT00127114]Amyotrophic Lateral Sclerosis and Frontotemporal Dementia [clinicaltrials:NCT00159198]clinicaltrials:NCT00176904Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients [clinicaltrials:NCT00200538]Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease [clinicaltrials:NCT00316498]Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C [clinicaltrials:NCT00344331]Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia [clinicaltrials:NCT00376051]clinicaltrials:NCT00410566A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia [clinicaltrials:NCT00416169]Language in Primary Progressive Aphasia [clinicaltrials:NCT00537004]clinicaltrials:NCT00545974clinicaltrials:NCT00594737clinicaltrials:NCT00604591PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia [clinicaltrials:NCT00613119]clinicaltrials:NCT00668564Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia [clinicaltrials:NCT00674960]P-glycoprotein Function in Brain Diseases [clinicaltrials:NCT00677885]Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells [clinicaltrials:NCT00730314]Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly [clinicaltrials:NCT00811122]clinicaltrials:NCT00821132Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease. [clinicaltrials:NCT00938665]clinicaltrials:NCT00950430Language Treatment for Progressive Aphasia [clinicaltrials:NCT00957710]clinicaltrials:NCT00975689Oxytocin and Social Cognition in Frontotemporal Dementia [clinicaltrials:NCT01002300]Davunetide (AL-108) in Predicted Tauopathies - Pilot Study [clinicaltrials:NCT01056965]Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls [clinicaltrials:NCT01147679]clinicaltrials:NCT01306604Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD) [clinicaltrials:NCT01353430]Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders [clinicaltrials:NCT01372228]Safety Study of Intranasal Oxytocin in Frontotemporal Dementia [clinicaltrials:NCT01386333]Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized [clinicaltrials:NCT01403519]Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders [clinicaltrials:NCT01459302]Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center [clinicaltrials:NCT01465360]clinicaltrials:NCT01586455A Composite MR Neuroimaging Marker for Alzheimer's Disease [clinicaltrials:NCT01615666]
condition browse [clinicaltrials_vocabulary:condition-browse]
PET Scan of Brain Metabolism in Relation to Age and Disease [clinicaltrials:NCT00001972]Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00005900]Direct Current Brain Polarization in Frontotemporal Dementia [clinicaltrials:NCT00077896]Treatment Study of Frontotemporal Dementia [clinicaltrials:NCT00088751]Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD) [clinicaltrials:NCT00127114]Amyotrophic Lateral Sclerosis and Frontotemporal Dementia [clinicaltrials:NCT00159198]clinicaltrials:NCT00176904Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients [clinicaltrials:NCT00200538]Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease [clinicaltrials:NCT00316498]Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C [clinicaltrials:NCT00344331]Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia [clinicaltrials:NCT00376051]clinicaltrials:NCT00410566A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia [clinicaltrials:NCT00416169]Language in Primary Progressive Aphasia [clinicaltrials:NCT00537004]clinicaltrials:NCT00545974clinicaltrials:NCT00594737clinicaltrials:NCT00604591PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia [clinicaltrials:NCT00613119]clinicaltrials:NCT00668564Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia [clinicaltrials:NCT00674960]P-glycoprotein Function in Brain Diseases [clinicaltrials:NCT00677885]Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells [clinicaltrials:NCT00730314]Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly [clinicaltrials:NCT00811122]clinicaltrials:NCT00821132Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease. [clinicaltrials:NCT00938665]clinicaltrials:NCT00950430Language Treatment for Progressive Aphasia [clinicaltrials:NCT00957710]clinicaltrials:NCT00975689Oxytocin and Social Cognition in Frontotemporal Dementia [clinicaltrials:NCT01002300]Davunetide (AL-108) in Predicted Tauopathies - Pilot Study [clinicaltrials:NCT01056965]Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls [clinicaltrials:NCT01147679]clinicaltrials:NCT01306604Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD) [clinicaltrials:NCT01353430]Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders [clinicaltrials:NCT01372228]Safety Study of Intranasal Oxytocin in Frontotemporal Dementia [clinicaltrials:NCT01386333]Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized [clinicaltrials:NCT01403519]Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders [clinicaltrials:NCT01459302]Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center [clinicaltrials:NCT01465360]clinicaltrials:NCT01586455A Composite MR Neuroimaging Marker for Alzheimer's Disease [clinicaltrials:NCT01615666]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Frontotemporal Dementia [clinicaltrials_resource:b64b03a2389f48acfcdff013beb89734]
Bio2RDF identifier
b64b03a2389f48acfcdff013beb89734
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b64b03a2389f48acfcdff013beb89734
identifier
clinicaltrials_resource:b64b03a2389f48acfcdff013beb89734
title
Frontotemporal Dementia
@en
type
label
Frontotemporal Dementia [clinicaltrials_resource:b64b03a2389f48acfcdff013beb89734]
@en
Frontotemporal Dementia